Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-03-25
1999-08-17
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514837, A61K 3170
Patent
active
059393971
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
This invention relates to treatment of cholera. More specifically, the invention concerns neutralization and elimination of cholera toxin. This invention also relates to binding and removal of Vibrio cholerae, the causative agent of cholera from the intestinal tract.
REFERENCES
The following references are cited in the application as numbers in
1. Merritt, Ethan A., et al., "Crystal structure of cholera toxin B-pentamer bound to receptor G.sub.M1 pentasaccharide", Protein Science, 3:166-175 (1994).
2. Spangler, Brenda D., "Structure and Function of Cholera Toxin and the Related Escherichia coli Heat-Labile Enterotoxin", Microbiological Reviews, 56, No. 4:622-647 (1992).
3. Eidels, L., et al., Membrane receptors for bacterial toxins, Microbiology Reviews, 47:596-620 (1983).
4. Fishman, Peter H., et al., "Gangliosides as Receptors for Bacterial Enterotoxins", Advances in Lipid Research, 25:165-187 (1993).
5. Lanne et al., "On the role of the carboxyl group of sialic acid in binding of cholera toxin to the receptor glycosphingolipid, GM1", J. Biochem., 116:1269-1274 (1994).
6. Schengrund et al., "Binding of Vibrio cholera toxin and heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1 and nonlipid oligosaccharide polyvalent ligands", J. Biol. Chem., 264:13233-13237 (1989).
7. Fukuda et al., "Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LTh-IIa, and Lth-IIb", Infect. Immun., 56:1748-1753(1988).
8. Uesaka et al., "Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose", Microb. Path., 16:71-76 (1994).
9. Tayot et al., "Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside", Eur. J. Biochem. 113:249-58 (1981).
10. Parikh et al., "Ganglioside-agarose and cholera toxin", Meth. Enzymol., 34:610-619(1974).
11. Lemieux, R. U., et al., "The properties of a `synthetic` antigen related to the blood-group Lewis A", J. Am. Chem. Soc., 97:4076-83 (1975).
12. Lemieux, R. U., et al., "Glycoside-Ether-Ester Compounds", U.S. Pat. No. 4,137,401, issued Jan. 30, 1979.
13. Lemieux, R. U., et al., "Artificial Oligosaccharide Antigenic Determinants", U.S. Pat. No. 4,238,473, issued Dec. 9, 1980.
14. Lemieux, R. U., et al., "Synthesis of 2-Amino-2-Deoxyglycoses and 2-Amino-2-Deoxyglycosides from glycals", U.S. Pat. No. 4,362,720, issued Dec. 7, 1982.
15. Cox, D., et al. "A New Synthesis of 4-0-.alpha.-D-Galactopyranosyl-D-Galacto-Pyranose", Carbohy. Res., 62:245-252 (1978).
16. Dahmen, J., et al., "Synthesis of space arm, lipid, and ethyl glycosides of the trisaccharide portion p.sup.k antigen: preparation of neoglycoproteins", Carbohydrate Research, 127:15-25 (1984).
17. Garegg, P. J., et al., "A Synthesis of 8-Methoxycarbonyloct-1-yl O-.alpha.-D-Galactopyranosyl-(1-3)-0-.beta.-D-Galactopyranosyl-(1-4)-2-Ace tamido-2-Deoxy-.beta.-D-Glucopyranoside", Carbohy. Res., 136:207-213 (1985).
18. Garegg, P. J., et al., "Synthesis of 6- and 6'-deoxy derivatives of methyl 4-0-.alpha.-D-galactopyranosyl-.beta.-D-galactopyranoside for studies of inhibition of pyelonephritogenic fimbriated E. coli adhesion to urinary epithelium-cell surfaces", Carbohy. Res., 137:270-275 (1985).
19. Jacquinet, J. C., et al., "Synthesis of Blood-group Substances, Part 11. Synthesis of the Trisaccharide O-.alpha.-D-Galactopyranosyl-(1-3)-0-.beta.-D-galactopyranosyl-(1-4)-2-ace tamido-2-deoxy-D-glucopyranose", J. C. S. Perkin, I:326-330 (1981).
20. Koike, K., et al., "Total Synthesis of Globotriaosyl-E and Z-Ceramides and Isoglobotriaosyl-E-Ceramide," Carbohydr. Res., 163:189-208 (1987).
21. Schaubach, R., et al., "Tumor-Associated Antigen Synthesis: Synthesis of the Gal-.alpha.-(1-3)-Gal-.beta.-(1-4)-GlcNAc Epitope. A specific Determinant for Metastatic Progression?", Liebigs Ann. Chem., 607-614 (1991).
22. Ratcliffe, R. M., et al., "Sialic Acid Glycosides, Antigens, Immunoadsorbents, and Methods for Their Preparation", U.S
REFERENCES:
patent: 5661131 (1997-08-01), Heerze et al.
Armstrong Glen D.
Heerze Louis D.
Jordan Kimberly
Synsorb Biotech Inc.
LandOfFree
Treatment of cholera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cholera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cholera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-314872